Brief: Bergenbio Announces NCI Clinical Collaboration With UT Health San Antonio And SOBI

Oncoinvent ASA

28/05/2024 14:14

May 28 (Reuters) - Bergenbio ASA  BGBIO.OL :
    * BERGENBIO ANNOUNCES NCI CLINICAL COLLABORATION WITH UT
HEALTH
SAN ANTONIO AND SOBI®
    * BERGENBIO, SOBI & UT HEALTH SAN ANTONIO PARTNER UP
    * PARTIES WILL COLLABORATE TO STUDY BERGENBIO'S SELECTIVE
AXL
INHIBITOR, BEMCENTINIB, IN COMBINATION WITH SOBI'S PACRITINIB IN
PATIENTS WITH ADVANCED LUNG ADENOCARCINOMA

Source text for Eikon:  ID:nObisWFkta 
Further company coverage:  BGBIO.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))